Category WTO/TRIPS

New International Pharma Industry Leader Brings Prospect Of Change

By William New
Alicia Greenidge represents a change for the global pharmaceutical and biotechnology industry, but as she grows into her role as the head of the industry's international trade association, it is unclear whether there will be substantive changes on policy relating to intellectual property and public health. Key policy areas include counterfeit medicines and funding for research and development into diseases afflicting poor populations in ways that echo past industry approaches, but Greenidge brings a new focus on networking and negotiation.

World Customs Organization To Replace Controversial IP Standards Body; Doubts Remain

By William New In what might be seen as a victory for defenders of flexibilities for poor nations in international trade rules, the World Customs Organization in December recommended the discontinuance of a working group on intellectual property enforcement standards…

Experts Examine Strategies For IP And Sustainable Development

By William New Developing nations increasingly are receiving tools to help them participate in and benefit from the global intellectual property system, according to a group of experts who met recently on IP strategies. And now is a critical time…

US IP Attachés Take Hard-Line Position On Overseas IP Enforcement

By Drew Clark for Intellectual Property Watch WASHINGTON, DC – Nations ranging from Brazil to Brunei to Russia are failing to properly protect the intellectual property assets of US companies and others, and international organisations are not doing enough to…

Lamy invita a los Miembros de la OMC descontentos a que usen el examen del Acuerdo sobre los ADPIC y la Salud Pública

Por William New Se afirma hace un tiempo que no están funcionando las disposiciones de la Organización Mundial del Comercio (OMC) destinadas a incrementar el acceso a los medicamentos de los países pobres. En respuesta a estas afirmaciones, el Director…

Pascal Lamy invite les membres de l’OMC mécontents à utiliser le réexamen de l’Accord sur les ADPIC et la santé publique

Par William New Mardi, face aux allégations de longue date qui nient l’efficacité des règles de l’Organisation mondiale du commerce (OMC) visant à améliorer l’accès aux médicaments dans les pays pauvres, le Directeur général de l’OMC, Pascal Lamy, a appelé…